Why Tonix Pharmaceuticals Holding Corp. (TNXP) Soared Last Week

We recently compiled a list of the 10 Micro-, Small-Cap Firms Were Last Week’s Top Performers. In this article, we are going to take a look at where Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) stands against the other stocks.

Micro- and small-cap companies dominated the stock market last week, clocking in impressive gains on the back of a flurry of catalysts that boosted investing appetite.

We named last week’s top 10 performers that outperformed the Russell 2000 index, which dropped by 4.04 percent week-on-week. Among them, one firm particularly stood out with its outstanding 317-percent jump, thanks to a $1-billion deal that could fuel its growth prospects.

To come up with the list, we considered the stocks with the highest week-on-week change, comparing their share prices on March 7 and February 28.

We classified micro-cap companies as those with a market capitalization below $300 million and small-cap firms as those with a market capitalization below $2 billion.

A scientist in a lab coat working with a microscope, researching a biopharmaceutical solution.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its share price surge by 65.6 percent week-on-week to end Friday at $13.02 versus $7.86 on February 28 as investors bought up shares ahead of an investor summit next week.

Investors repositioned portfolios following news that Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) would present at the 2025 Virtual Investor Summit on Tuesday, March 11, where they would closely look out for cues and updates on its TNX-102 SL, a priority product candidate that aims to manage fibromyalgia.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) said it expects to receive the decision of the Food and Drug Administration on the marketing authorization of the product on August 15, 2025.

Apart from TNX-102 SL, its portfolio also includes TNX-1300, a biologic in Phase 2 development designed to treat cocaine intoxication.

Overall TNXP ranks 3rd on our list of last week’s top performers. While we acknowledge the potential of TNXP as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than TNXP but trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.